Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2015-10-12
|
evacetrapib |
patients with high-risk atherosclerotic cardiovascular disease |
3 |
Eli Lilly (USA - IN) |
Cardiovascular diseases |
2015-10-12
|
Viaskin® |
Crohn's disease |
|
DBV Technologies (France) |
Autoimmune diseases - Inflammatory diseases - Digestive diseases |
2015-10-12
|
romosozumab (CDP7851/AMG 785) |
postmenopausal women with low bone mineral density |
2 |
Amgen (USA - CA) UCB (Belgium) |
Bone diseases - Women's health |
2015-10-10
|
ceftazidime/avibactam (CAZ-AVI) |
complicated urinary tract infections (cUTI) |
|
Allergan (Ireland) |
Infectious diseases |
2015-10-10
|
Cosentyx® - secukinumab (AIN457) |
psoriasis |
3 |
Novartis (Switzerland) |
Autoimmune diseases - Dermatological diseases |
2015-10-10
|
VX-440 |
cystic fibrosis |
1 |
Vertex Pharmaceuticals (USA - MA) |
Rare diseases - Genetic diseases |
2015-10-10
|
VX-152 |
cystic fibrosis |
|
Vertex Pharmaceuticals (USA - MA) |
Rare diseases - Genetic diseases |
2015-10-09
|
delafloxacin |
acute bacterial skin and skin structure infections (ABSSSI) |
3 |
Melinta Therapeutics (USA - CT) |
Infectious diseases |
2015-10-09
|
Ad26.ZEBOV and MVA-BN-Filo |
Ebola fever |
3 |
Crucell Holland, a J&J company (USA - NJ) |
Infectious diseases |
2015-10-09
|
Trumenba® - rLP2086 coadministered with routine meningococcal (groups A, C, Y and W) (MCV4) and tetanus, diphtheria and pertussis (Tdap) vaccines |
|
2 |
Pfizer (USA - NY) |
Infectious diseases |
2015-10-09
|
GLPG1837 |
cystic fibrosis |
1 |
Abbvie (USA - IL) Galapagos (Belgium) |
Rare diseases - Genetic diseases |
2015-10-09
|
KUR-211 |
tibial plateau fractures that require fixation and grafting |
2b |
KUROS Biosurgery (Switzerland) |
Bone diseases |
2015-10-08
|
BI 655066 |
moderate-to-severe plaque psoriasis |
2 |
Boehringer Ingelheim (Germany) |
Autoimmune diseases - Dermatological diseases |
2015-10-08
|
Gilenya® (fingolimod) |
relapsing forms of multiple sclerosis |
3 |
Novartis (Switzerland) |
Autoimmune diseases - Neurodegenerative diseases |
2015-10-08
|
Lemtrada® (alemtuzumab) |
multiple sclerosis |
3 |
Genzyme (USA - MA), a Sanofi company (France) |
Autoimmune diseases - Neurodegenerative diseases |
2015-10-08
|
SAR428926 |
advanced solid tumors |
1 |
Sanofi |
Cancer - Oncology |
2015-10-07
|
C1 derived vaccine |
|
preclinical |
Dyadic (USA - FL) Sanofi Pasteur (France) |
Infectious diseases - Veterinary medicine |
2015-10-07
|
Aubagio® (teriflunomide) |
relapsing multiple sclerosis (RMS) |
3 |
Genzyme (USA - MA), a Sanofi company (France) |
Autoimmune diseases - Neurodegenerative diseases |
2015-10-06
|
BioChaperone Lispro® U100 |
patients with type 1 diabetes using insulin pump therapy |
1b |
Adocia (France) Eli Lilly (USA - IN) |
Metabolic diseases |
2015-10-06
|
RVT-101 |
Alzheimer\'s disease |
3 |
Axovant Sciences (Bermuda - USA - NY) |
Neurodegenerative diseases |